Inflammatory Myopathy: Clinical Trials

1 trial for Inflammatory Myopathy, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 not yet recruiting. 1 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 21Not yet recruiting 1
Phase 31Not yet recruiting 1

Follow Inflammatory Myopathy: new trials by email Literature Review of Inflammatory Myopathy trials Research Report on Inflammatory Myopathy

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
TELITACICEPT IN INFLAMMATORY MYOPATHIES(TELITACICEPT-IM)
Telitacicept 240mg - Inflammatory Myopathy
Phase 2 / Phase 3Not yet recruitingZhongming Qiu302026-02-022026-01-21

Narrower conditions

Myositis (1)

Broader conditions

Muscular Diseases (1)  ·  Musculoskeletal Diseases (1)  ·  Nervous System Diseases (1)  ·  Neuromuscular Diseases (1)

Interventions

telitacicept (1)

Sponsors

Zhongming Qiu (1)